Fredun Pharmaceuticals informs about board meeting

19 Jun 2018 Evaluate

In compliance to Regulation 33 read with Regulation 30 along with Part A of Schedule 111 of SEBl Listing Regulations, 2015, Fredun Pharmaceuticals has informed that the Board of Directors of the Company, at its Meeting held on Monday, June 18, 2018, have considered and approved the Audited Financials for the year ended March 31, 2018.

The above information is a part of company’s filings submitted to BSE.

Fredun Pharma Share Price

718.60 11.75 (1.66%)
27-Nov-2024 11:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1753.30
Dr. Reddys Lab 1201.00
Cipla 1478.25
Lupin 2015.10
Zydus Lifesciences 955.35
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.